Acute hepatitis A; Cytotoxic T lymphocyte-associated antigen 4; Programmed death 1
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to evaluate the relationship between controlled attenuation parameter (CAP) and hepatic steatosis, as assessed by ultrasound (US) in patients with alcoholic liver disease (ALD) or non-alcoholic fatty liver disease (NAFLD). Methods: Patients with either ALD or NAFLD who were diagnosed with fatty liver with US and whose CAP scores were measured, were retrospectively enrolled in this study. The degree of hepatic steatosis assessed by US was categorized into mild (S1), moderate (S2), and severe (S3). Results: A total of 186 patients were included: 106 with NAFLD and 80 with ALD. Regarding hepatic steatosis, the CAP score was significantly correlated with US (ρ=0.580, p<0.001), and there was no significant difference between the NAFLD and ALD groups (ρ=0.569, p<0.001; ρ=0.519, p<0.001; p=0.635). Using CAP, area under receiver operating characteristic curves for ≥S2 and ≥S3 steatosis were excellent (0.789 and 0.843, respectively). For sensitivity ≥90%, CAP cutoffs for the detection of ≥S2 and ≥S3 steastosis were separated with a gap of approximately 35 dB/m in all patients and in each of the NAFLD and ALD groups. Conclusions: The CAP score is well correlated with hepatic steatosis, as assessed by US, in both ALD and NAFLD.
Abstract
Background/Aims: The aim of this study was to evaluate the relationship between controlled attenuation parameter (CAP) and hepatic steatosis, as assessed by ultrasound (US) in patients with alcoholic liver disease (ALD) or non-alcoholic fatty liver disease (NAFLD). Methods: Patients with either ALD or NAFLD who were diagnosed with fatty liver with US and whose CAP scores were measured, were retrospectively enrolled in this study. The degree of hepatic steatosis assessed by US was categorized into mild (S1), moderate (S2), and severe (S3). Results: A total of 186 patients were included: 106 with NAFLD and 80 with ALD. Regarding hepatic steatosis, the CAP score was significantly correlated with US (ρ=0.580, p<0.001), and there was no significant difference between the NAFLD and ALD groups (ρ=0.569, p<0.001; ρ=0.519, p<0.001; p=0.635). Using CAP, area under receiver operating characteristic curves for ≥S2 and ≥S3 steatosis were excellent (0.789 and 0.843, respectively). For sensitivity ≥90%, CAP cutoffs for the detection of ≥S2 and ≥S3 steastosis were separated with a gap of approximately 35 dB/m in all patients and in each of the NAFLD and ALD groups. Conclusions: The CAP score is well correlated with hepatic steatosis, as assessed by US, in both ALD and NAFLD.
참고문헌 (24)
- Levene AP, "The epidemiology, pathogenesis and histopathology of fatty liver disease", Histopathology, 61, pp.141~152 (2012)
- Lazo M, "The epidemiology of nonalcoholic fatty liver disease: a global perspective", Semin Liver Dis, 28, pp.339~350 (2008)
- Bellentani S, "Prevalence of and risk factors for hepatic steatosis in Northern Italy", Ann Intern Med, 132, pp.112~117 (2000)
- Cerović I, "Alcoholic liver disease", nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease, 2013, pp.25, 899~904
- Myers RP, "Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography", Liver Int, 32, pp.902~910 (2012)
- Yeh MM, "Pathological features of fatty liver disease", Gastroenterology, 147, pp.754~764 (2014)
- Tuyama AC, "Non-alcoholic fatty liver disease", J Diabetes, 4, pp.266~280 (2012)
- Starley BQ, "Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection", Hepatology, 51, pp.1820~1832 (2010)
- Sung KC, "Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people", Diabetes Care, 35, pp.2359~2364 (2012)
- Rockey DC, "Liver biopsy", Hepatology, 49, pp.1017~1044 (2009)
- Grant A, "Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology", Gut, 45(4), pp.IV1~IV11 (1999)
- Bohte AE, "The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis", Eur Radiol, 21, pp.87~97 (2011)
- Schwenzer NF, "Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance", J Hepatol, 51, pp.433~445 (2009)
- Hamaguchi M, "The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation", Am J Gastroenterol, 102, pp.2708~2715 (2007)
- Dasarathy S, "Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study", J Hepatol, 51, pp.1061~1067 (2009)
- de Lédinghen V, "Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations", J Hepatol, 60, pp.1026~1031 (2014)
- Sasso M, "Controlled attenuation parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis. Preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound Med Biol, 36, pp.1825~1835 (2010)
- Sasso M, "The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan", Clin Res Hepatol Gastroenterol, 36, pp.13~20 (2012)
- Castera L, "Non-invasive evaluation of liver fibrosis using transient elastography", J Hepatol, 48, pp.835~847 (2008)
- de Lédinghen V, "Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography", Liver Int, 32, pp.911~918 (2012)
- Chon YE, "Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population", Liver Int, 34, pp.102~109 (2014)
- Kumar M, "Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?", J Gastroenterol Hepatol, 28, pp.1194~1201 (2013)
- Carvalhana S, "How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound", Liver Int, 34, pp.e111~e117 (2014)
- Scaglioni F, "ASH and NASH", Dig Dis, 29, pp.202~210 (2011)